Skip to main content

Follow us

Home

Search

the Gateway to Research in Oklahoma

  • Researchers
  • Providers
  • Patients
  • About GRO

Gateway to Research in Oklahoma


Oklahoma Shared Clinical and Translational Resources U54 GM104938

Researchers

imgResearchers

The GRO: Researcher Portal provides resources, information, and training to help individuals or communities involved in performing clinical and translational research in Oklahoma.

Providers

imgProviders

The GRO: Provider Portal assists medical providers to identify clinical research opportunities in Oklahoma, tools for patient education, and evidence-based resources to improve patient care.

Patients

imgPatients

The GRO: Patient Portal can help patients and families to learn more about clinical and translational research and to connect with opportunities to participate in research opportunities in your communities.

Oklahoma Research Highlights

Safety and Efficacy of Frexalimab from the Phase 2 Open-label Extension in Participants with Relapsing Multiple Sclerosis: 2-year Results (S3.006)

3 months ago
CONCLUSIONS: Frexalimab continues to show favorable safety and sustained reduction in disease activity in pwRMS through W96, supporting its further development in phase 3 trials as a potential high-efficacy, non-lymphocyte-depleting therapy. Disclosure: Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck....
Patrick Vermersch

Reversible Cerebral Vasoconstriction Syndrome Following Lumbar Puncture for Idiopathic Intracranial Hypertension (P5-14.015)

3 months ago
CONCLUSIONS: Lowering intracranial pressure in the setting of IIH is a novel etiology for RCVS that has not been described before. Disclaimer: Abstracts were not reviewed by Neurology® and do not reflect the views of Neurology® editors or staff. Disclosure: Dr. Mardini has nothing to disclose. Shivaansh Aggarwal, MD has nothing to disclose. Dr. Singh has nothing to disclose. Dr. Al-Awwad has nothing to disclose.
Mhd Majd Mardini

Young children's representation of local information (angle and length) for relocation

3 months ago
As local spatial cues, angle and length information are known to be effective cues for relocation in adults, yet young children often struggle with using such information. We propose that the previously found late utilization of local geometric cues might be partly attributed to the testing environments, where connected enclosures provided immediate access to its global shape. Here, we investigated at what age children acquire the ability to relocate using local angle and length information in...
Ganzhen Feng

Comparing durvalumab, olaparib, and cediranib monotherapy, combination therapy, or chemotherapy in patients with platinum-resistant ovarian cancer with prior bevacizumab: the phase II NRG-GY023 trial

3 months ago
CONCLUSION: In PROC patients with prior bevacizumab, all experimental arms failed to reach the primary objective of improving PFS compared with SOC.
Jung-Min Lee

Observation of Ergodicity Breaking and Quantum Many-Body Scars in Spinor Gases

3 months ago
We experimentally and theoretically demonstrate that spinor gases driven by spin-flopping fields are excellent platforms for investigating ergodicity breaking and quantum scarring. We observe that specific initial states remain nonthermal at weak driving despite the majority of states thermalizing, which constitutes clear evidence of quantum many-body scars (QMBSs). As the driving strength increases, the experimental system undergoes a smooth transition from integrable to weakly ergodicity...
J O Austin-Harris

Pagination

  • Previous page ‹ Previous
  • Page 30
  • Next page Next ›
Subscribe to

octsi logo

1000 N. Lincoln Blvd, Suite 2100, Oklahoma City, OK 73104
Copyright © 2021 The Board of Regents of the University of Oklahoma, All Rights Reserved.

About GRO

News
Publications
FAQ

Terms of Use

Privacy Policy
Accessibility

Contact

info email
info phone
Copyright © 2025. All rights reserved. Designed By Zymphonies